We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiologic Data of Patients in a Teaching Hospital

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00114335
First Posted: June 15, 2005
Last Update Posted: October 10, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Luzerner Kantonsspital
  Purpose

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system

Condition
Kidney Diseases Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Impaired Renal Function in Medical Inpatients

Further study details as provided by Luzerner Kantonsspital:

Enrollment: 352
Study Start Date: May 2005
Study Completion Date: July 2005
Detailed Description:

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine
Criteria

Inclusion Criteria:

  • All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00114335


Locations
Switzerland
Kantonsspital Luzern
Luzern, LU, Switzerland, 6000
Sponsors and Collaborators
Luzerner Kantonsspital
Investigators
Principal Investigator: P Schmid, MD Kantonsspital Luzern, Hematology
Study Director: A G Fischer, MD Kantonsspital Luzern, Nephrology
Study Chair: W A Wuillemin, MD, PhD Kantonsspital Luzern, Hematology
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00114335     History of Changes
Other Study ID Numbers: LMWHplus_1
First Submitted: June 14, 2005
First Posted: June 15, 2005
Last Update Posted: October 10, 2008
Last Verified: October 2008

Keywords provided by Luzerner Kantonsspital:
low molecular weight heparin
unfractionated heparin

Additional relevant MeSH terms:
Kidney Diseases
Urologic Diseases